IDEAYA Biosciences Announces Plans for Investor R&D Day and Participation in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Nov. 1, 2022 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in investor conferences in...

Click to view original post